The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...
A Phase 1b clinical trial testing pociredir in adults with sickle cell disease has completed enrollment of its high-dose ...
LMP Capital and Income Fund offers a 9.7% yield, focusing on income generation through a diversified asset mix. See why SCD ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...
A specialist from Oman, located at the crossroads of Africa and Asia, explains that his nation serves as a microcosm when it ...
The Punch on MSN
SCD and the burden of care – Part 2
In Part 1 of SCD and the burden of care, we explored the emotional, physical, and financial weight that families carry while supporting a loved one living with sickle cell disease.We looked at how ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback